PUS1 is a novel biomarker for predicting poor outcomes and triple-negative status in breast cancer

Overview of attention for article published in Frontiers in oncology, November 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 5 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 24,127 followers.

PUS1 is a novel biomarker for predicting poor outcomes and triple-negative status in breast cancer https://t.co/tV5mNBEtR4 https://t.co/06bWrD55VL

02 Dec 2022

Reply Repost Favourite

PUS1 is a novel biomarker for predicting poor outcomes and triple-negative status in breast cancer https://t.co/gSCuC6eGRN https://t.co/6bWrl9a1Om

16 Nov 2022

Reply Repost Favourite

New research: PUS1 is a novel biomarker for predicting poor outcomes and triple-negative status in breast cancer: Breast cancer patients’ outcomes have improved dramatically in recent years, but relapses and poor prognosis remain common due to… https://t.c

15 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.